Published in FEBS Lett on February 03, 2012
Neoadjuvant therapy for pancreas cancer: past lessons and future therapies. World J Gastroenterol (2014) 0.93
Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps. Oncogenesis (2015) 0.88
Direct Regulation of Alternative Splicing by SMAD3 through PCBP1 Is Essential to the Tumor-Promoting Role of TGF-β. Mol Cell (2016) 0.81
Smad4 loss promotes lung cancer formation but increases sensitivity to DNA topoisomerase inhibitors. Oncogene (2015) 0.79
Integrated Genomic Analysis of Pancreatic Ductal Adenocarcinomas Reveals Genomic Rearrangement Events as Significant Drivers of Disease. Cancer Res (2015) 0.79
BxPC3 pancreatic cancer cells express a truncated Smad4 protein upon PI3K and mTOR inhibition. Oncol Lett (2014) 0.77
KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment. Cancers (Basel) (2016) 0.77
Genome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival. PLoS One (2015) 0.77
Redirecting RNA splicing by SMAD3 turns TGF-β into a tumor promoter. Mol Cell Oncol (2016) 0.75
Antitumor effects of recombinant human adenovirus-p53 against human cutaneous squamous cell carcinoma in mice. Exp Ther Med (2016) 0.75
Chromodomain-helicase-DNA binding protein 5, 7 and pronecrotic mixed lineage kinase domain-like protein serve as potential prognostic biomarkers in patients with resected pancreatic adenocarcinomas. World J Gastrointest Oncol (2016) 0.75
miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer. Sci Rep (2017) 0.75
Fibronectin-guided migration of carcinoma collectives. Nat Commun (2017) 0.75
Smad4 restricts differentiation to promote expansion of satellite cell derived progenitors during skeletal muscle regeneration. Elife (2016) 0.75
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
The consensus coding sequences of human breast and colorectal cancers. Science (2006) 60.02
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature (2005) 26.32
Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature (2005) 19.13
Smad transcription factors. Genes Dev (2005) 13.43
Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development (2002) 12.21
Specificity and versatility in tgf-beta signaling through Smads. Annu Rev Cell Dev Biol (2005) 11.18
Suppression of human colorectal carcinoma cell growth by wild-type p53. Science (1990) 11.18
DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (1996) 11.13
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science (2011) 11.12
Role of transforming growth factor beta in human disease. N Engl J Med (2000) 10.17
Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med (2009) 10.01
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (1991) 9.89
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 9.23
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat Rev Cancer (2003) 8.35
The role of the transcriptional regulator Ptf1a in converting intestinal to pancreatic progenitors. Nat Genet (2002) 8.28
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol (2009) 6.43
New insights into TGF-beta-Smad signalling. Trends Biochem Sci (2004) 6.13
Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol (1999) 5.58
Non-Smad pathways in TGF-beta signaling. Cell Res (2009) 5.54
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev (2006) 5.53
Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J (1999) 5.49
Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature (1996) 5.21
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet (1994) 4.63
SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature (2011) 4.57
Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res (1997) 4.54
A human Mad protein acting as a BMP-regulated transcriptional activator. Nature (1996) 4.36
Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell (1998) 4.22
MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell (1996) 4.13
Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet (1996) 4.09
Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev (2005) 4.05
Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet (2011) 3.93
Smad3 mutant mice develop metastatic colorectal cancer. Cell (1998) 3.92
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Cancer Res (2000) 3.74
Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature (1998) 3.65
Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev (2003) 3.58
Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol (1999) 3.55
Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol (2002) 3.52
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res (1988) 3.31
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02
Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med (2010) 2.79
Epithelial to mesenchymal transition predicts gefitinib resistance in cell lines of head and neck squamous cell carcinoma and non-small cell lung carcinoma. Mol Cancer Ther (2007) 2.71
Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell (1998) 2.60
Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature (2006) 2.60
High incidence of head and neck squamous cell carcinoma in patients with Fanconi anemia. Arch Otolaryngol Head Neck Surg (2003) 2.56
Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome. Nat Genet (2011) 2.52
Mad-related genes in the human. Nat Genet (1996) 2.51
The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci U S A (1998) 2.51
SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res (2009) 2.44
SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion. Nat Genet (2007) 2.39
Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell (2007) 2.36
Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene (1999) 2.22
Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res (2006) 2.19
Hamartomatous polyposis syndromes. Nat Clin Pract Gastroenterol Hepatol (2007) 2.16
Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med (2004) 2.05
The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis. Gastroenterology (2000) 2.04
Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest (2006) 2.03
Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest (2009) 1.95
Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc Natl Acad Sci U S A (1998) 1.94
Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis. J Am Soc Nephrol (2010) 1.89
Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest (2008) 1.88
Deletion of Smad2 in mouse liver reveals novel functions in hepatocyte growth and differentiation. Mol Cell Biol (2006) 1.82
DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma. J Clin Oncol (2002) 1.78
Frequency of Smad gene mutations in human cancers. Cancer Res (1997) 1.73
Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Am J Pathol (2001) 1.69
Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Cancer Res (2007) 1.66
Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene (2000) 1.65
p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene (1993) 1.62
Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma. Clin Cancer Res (2005) 1.56
Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. Cancer Cell (2006) 1.54
Smad3 deficiency promotes tumorigenesis in the distal colon of ApcMin/+ mice. Cancer Res (2006) 1.52
Bone morphogenetic protein signalling in colorectal cancer. Nat Rev Cancer (2008) 1.49
Gastric and duodenal polyps in Smad4 (Dpc4) knockout mice. Cancer Res (1999) 1.48
Meta-analysis of immunohistochemical prognostic markers in resected pancreatic cancer. Br J Cancer (2011) 1.45
Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice. Development (2003) 1.43
Targeted disruption of Smad4 in mouse epidermis results in failure of hair follicle cycling and formation of skin tumors. Cancer Res (2005) 1.43
Hair follicle defects and squamous cell carcinoma formation in Smad4 conditional knockout mouse skin. Oncogene (2006) 1.42
Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc Natl Acad Sci U S A (1999) 1.41
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res (1996) 1.41
Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Cancer Res (2001) 1.40
Transforming growth factor-beta suppresses nonmetastatic colon cancer through Smad4 and adaptor protein ELF at an early stage of tumorigenesis. Cancer Res (2005) 1.37
Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis. Cancer J (2003) 1.35
Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am J Pathol (2000) 1.30
Molecular analysis of microdissected tumors and preneoplastic intraductal lesions in pancreatic carcinoma. Am J Pathol (2000) 1.28
Loss of the Smad3 expression increases susceptibility to tumorigenicity in human gastric cancer. Oncogene (2004) 1.25
DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res (1996) 1.22
Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene (1999) 1.21
Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene (1997) 1.21
Expression of Smad proteins in human colorectal cancer. Int J Cancer (1999) 1.21
Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res (2000) 1.19
SMAD2 is essential for TGF beta-mediated Th17 cell generation. J Biol Chem (2010) 1.18
Smad2 positively regulates the generation of Th17 cells. J Biol Chem (2010) 1.17
Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype. Cancer Res (2008) 1.14
Smad3 regulates senescence and malignant conversion in a mouse multistage skin carcinogenesis model. Cancer Res (2003) 1.11
Expression of G1-S modulators (p53, p16, p27, cyclin D1, Rb) and Smad4/Dpc4 in intrahepatic cholangiocarcinoma. Hum Pathol (2002) 1.11
Smad4 and transforming growth factor beta1 expression in patients with squamous cell carcinoma of the esophagus. Clin Cancer Res (2002) 1.10
Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4. Cancer Lett (2006) 1.09
Promoter methylation correlates with reduced Smad4 expression in advanced prostate cancer. Prostate (2008) 1.08
CIP2A inhibits PP2A in human malignancies. Cell (2007) 5.28
Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy. Nat Med (2011) 4.68
Mechanisms of gamma oscillations. Annu Rev Neurosci (2012) 4.58
A recurrent network mechanism of time integration in perceptual decisions. J Neurosci (2006) 4.53
Cortico-basal ganglia circuit mechanism for a decision threshold in reaction time tasks. Nat Neurosci (2006) 4.36
What determines the frequency of fast network oscillations with irregular neural discharges? I. Synaptic dynamics and excitation-inhibition balance. J Neurophysiol (2003) 3.54
Neuronal basis of age-related working memory decline. Nature (2011) 3.15
The importance of mixed selectivity in complex cognitive tasks. Nature (2013) 3.05
Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res (2007) 3.02
Cellular and network mechanisms of slow oscillatory activity (<1 Hz) and wave propagations in a cortical network model. J Neurophysiol (2003) 2.92
Interneuron Diversity series: Circuit complexity and axon wiring economy of cortical interneurons. Trends Neurosci (2004) 2.68
NMDA receptors subserve persistent neuronal firing during working memory in dorsolateral prefrontal cortex. Neuron (2013) 2.46
Loss of transforming growth factor-beta type II receptor promotes metastatic head-and-neck squamous cell carcinoma. Genes Dev (2006) 2.46
Variance as a signature of neural computations during decision making. Neuron (2011) 2.42
Smad7-induced beta-catenin degradation alters epidermal appendage development. Dev Cell (2006) 2.41
Two calcium-dependent protein kinases, CPK4 and CPK11, regulate abscisic acid signal transduction in Arabidopsis. Plant Cell (2007) 2.40
The role of default network deactivation in cognition and disease. Trends Cogn Sci (2012) 2.39
Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet (2011) 2.32
Smad7 binds to the adaptors TAB2 and TAB3 to block recruitment of the kinase TAK1 to the adaptor TRAF2. Nat Immunol (2007) 2.09
Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest (2005) 1.98
Smad4 loss in mice causes spontaneous head and neck cancer with increased genomic instability and inflammation. J Clin Invest (2009) 1.95
Similarity effect and optimal control of multiple-choice decision making. Neuron (2008) 1.88
Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest (2008) 1.88
Robust spatial working memory through homeostatic synaptic scaling in heterogeneous cortical networks. Neuron (2003) 1.85
Neural circuit dynamics underlying accumulation of time-varying evidence during perceptual decision making. Front Comput Neurosci (2007) 1.85
Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol (2004) 1.77
Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J (2004) 1.75
A biophysically based neural model of matching law behavior: melioration by stochastic synapses. J Neurosci (2006) 1.72
Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res (2004) 1.71
The stability of a stochastic CaMKII switch: dependence on the number of enzyme molecules and protein turnover. PLoS Biol (2005) 1.70
Neural dissociation of delay and uncertainty in intertemporal choice. J Neurosci (2008) 1.68
Transforming growth factor-β signaling promotes pulmonary hypertension caused by Schistosoma mansoni. Circulation (2013) 1.68
A recurrent network model of somatosensory parametric working memory in the prefrontal cortex. Cereb Cortex (2003) 1.66
A reservoir of time constants for memory traces in cortical neurons. Nat Neurosci (2011) 1.66
IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation. Proc Natl Acad Sci U S A (2008) 1.66
A specialized NMDA receptor function in layer 5 recurrent microcircuitry of the adult rat prefrontal cortex. Proc Natl Acad Sci U S A (2008) 1.61
A neural circuit model of flexible sensorimotor mapping: learning and forgetting on multiple timescales. Neuron (2007) 1.56
Contributions of intrinsic membrane dynamics to fast network oscillations with irregular neuronal discharges. J Neurophysiol (2005) 1.42
Genome-wide expression profiling of five mouse models identifies similarities and differences with human psoriasis. PLoS One (2011) 1.41
Temporally irregular mnemonic persistent activity in prefrontal neurons of monkeys during a delayed response task. J Neurophysiol (2003) 1.41
Inducible activation of oncogenic K-ras results in tumor formation in the oral cavity. Cancer Res (2004) 1.40
Angular path integration by moving "hill of activity": a spiking neuron model without recurrent excitation of the head-direction system. J Neurosci (2005) 1.39
Internal representation of task rules by recurrent dynamics: the importance of the diversity of neural responses. Front Comput Neurosci (2010) 1.37
Synaptic computation underlying probabilistic inference. Nat Neurosci (2009) 1.36
Mean-driven and fluctuation-driven persistent activity in recurrent networks. Neural Comput (2007) 1.35
NMDA receptor function in large-scale anticorrelated neural systems with implications for cognition and schizophrenia. Proc Natl Acad Sci U S A (2012) 1.32
The dynamical stability of reverberatory neural circuits. Biol Cybern (2002) 1.30
Proactive inhibitory control and attractor dynamics in countermanding action: a spiking neural circuit model. J Neurosci (2009) 1.29
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. Mol Oncol (2013) 1.28
A neural circuit basis for spatial working memory. Neuroscientist (2004) 1.28
An integrated microcircuit model of attentional processing in the neocortex. J Neurosci (2007) 1.28
Overexpression of Smad7 results in severe pathological alterations in multiple epithelial tissues. EMBO J (2002) 1.25
Essential roles of BMPR-IA signaling in differentiation and growth of hair follicles and in skin tumorigenesis. Genesis (2004) 1.22
The dynamical response properties of neocortical neurons to temporally modulated noisy inputs in vitro. Cereb Cortex (2008) 1.22
Inhibitory control by an integral feedback signal in prefrontal cortex: a model of discrimination between sequential stimuli. Proc Natl Acad Sci U S A (2005) 1.20
From distributed resources to limited slots in multiple-item working memory: a spiking network model with normalization. J Neurosci (2012) 1.20
Overexpression of microRNA OsmiR397 improves rice yield by increasing grain size and promoting panicle branching. Nat Biotechnol (2013) 1.20
Bursting neurons signal input slope. J Neurosci (2002) 1.17
Neural mechanism for stochastic behaviour during a competitive game. Neural Netw (2006) 1.15
In utero activation of K5.CrePR1 induces gene deletion. Genesis (2002) 1.14
8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder. J Immunol (2010) 1.13
Abscisic acid stimulates a calcium-dependent protein kinase in grape berry. Plant Physiol (2006) 1.12
Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer. Cancer Res (2009) 1.11
Same or different? A neural circuit mechanism of similarity-based pattern match decision making. J Neurosci (2011) 1.09
Linking microcircuit dysfunction to cognitive impairment: effects of disinhibition associated with schizophrenia in a cortical working memory model. Cereb Cortex (2012) 1.09
Mouse models for human head and neck squamous cell carcinomas. Head Neck (2006) 1.07
MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol (2012) 1.07
K14-GLp65 transactivator induces transgene expression in embryonic epidermis. Genesis (2002) 1.06
Epidermal Smad4 deletion results in aberrant wound healing. Am J Pathol (2009) 1.06
MicroRNA-137 targets carboxyl-terminal binding protein 1 in melanoma cell lines. Int J Biol Sci (2011) 1.06
Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer. Cancer Res (2013) 1.06
Cannabinoid-mediated disinhibition and working memory: dynamical interplay of multiple feedback mechanisms in a continuous attractor model of prefrontal cortex. Cereb Cortex (2007) 1.06
Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer Res (2004) 1.05
The role of Smads in skin development. J Invest Dermatol (2008) 1.04
Loss of serum response factor in keratinocytes results in hyperproliferative skin disease in mice. J Clin Invest (2009) 1.03
The Arabidopsis Ca(2+) -dependent protein kinase CPK12 negatively regulates abscisic acid signaling in seed germination and post-germination growth. New Phytol (2011) 1.03
Roles of TGFβ signaling Smads in squamous cell carcinoma. Cell Biosci (2011) 1.02
Tuning curve shift by attention modulation in cortical neurons: a computational study of its mechanisms. Cereb Cortex (2005) 1.02
Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. J Clin Invest (2013) 1.01
Power-law neuronal fluctuations in a recurrent network model of parametric working memory. J Neurophysiol (2005) 1.01
Reconciling coherent oscillation with modulation of irregular spiking activity in selective attention: gamma-range synchronization between sensory and executive cortical areas. J Neurosci (2010) 1.00
Stability of discrete memory states to stochastic fluctuations in neuronal systems. Chaos (2006) 0.99
Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis. PLoS One (2013) 0.99
The pro-inflammatory role of TGFβ1: a paradox? Int J Biol Sci (2012) 0.97
Loss of transforming growth factor beta type II receptor increases aggressive tumor behavior and reduces survival in lung adenocarcinoma and squamous cell carcinoma. Clin Cancer Res (2012) 0.97
From biophysics to cognition: reward-dependent adaptive choice behavior. Curr Opin Neurobiol (2008) 0.96
Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis. Free Radic Biol Med (2004) 0.96
Reactivation of developmentally expressed p63 isoforms predisposes to tumor development and progression. Cancer Res (2006) 0.95
Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol (2011) 0.95
Role of TGFbeta in skin inflammation and carcinogenesis. Mol Carcinog (2006) 0.94
Expression of a grape calcium-dependent protein kinase ACPK1 in Arabidopsis thaliana promotes plant growth and confers abscisic acid-hypersensitivity in germination, postgermination growth, and stomatal movement. Plant Mol Biol (2007) 0.94
Identification of a novel missense mutation of MSX1 gene in Chinese family with autosomal-dominant oligodontia. Arch Oral Biol (2008) 0.94
Transcriptional down-regulation of Brca1 and E-cadherin by CtBP1 in breast cancer. Mol Carcinog (2011) 0.94
HGF upregulation contributes to angiogenesis in mice with keratinocyte-specific Smad2 deletion. J Clin Invest (2010) 0.93
Distinct roles of individual Smads in skin carcinogenesis. Mol Carcinog (2007) 0.92
A common cortical circuit mechanism for perceptual categorical discrimination and veridical judgment. PLoS Comput Biol (2008) 0.91
In vitro cellular responses to scaffolds containing two microencapulated growth factors. Biomaterials (2009) 0.91
Influx of extracellular Ca2+ involved in jasmonic-acid-induced elevation of [Ca2+]cyt and JR1 expression in Arabidopsis thaliana. J Plant Res (2006) 0.90
Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis. Nat Med (2013) 0.90
Smad4-dependent desmoglein-4 expression contributes to hair follicle integrity. Dev Biol (2008) 0.89